Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)


Register Now for Upcoming ASCO Lung Cancer Highlights Webinar!
Howard (Jack) West, MD

GRACE LUNGevity horiz logo AIt's time for an annual favorite, the webinar by GRACE and LUNGevity Foundation focusing on highlights in lung cancer from the ASCO conference, the largest cancer meeting of the year.  

Join us on Thursday, July 18th, at 7 PM Eastern, 4 PM Pacific, for an approximately 90 minute program featuring two great guest experts. We'll be featuring Dr. David Gerber, Associate Professor at University of Texas-Southwestern in Dallas, and Dr. Eddie Garon, UCLA Medical Center in Los Angeles.

David Gerber, MD David Gerber, MD

We'll start with Dr. Gerber covering questions about locally advanced NSCLC, various current treatment options for first line and maintenance therapy, and also some work on maintenance therapy in extensive stage SCLC.

Edward Garon, MD Edward Garon, MD

Dr. Garon will then focus on a wide range of novel therapies, ranging from immunotherapies to second generation ALK inhibitors to a few potentially helpful new targeted therapy approaches that could become useful treatment options in advanced NSCLC.

Following their presentations, we'll open things up for questions about these new areas of research. The content will be available in the form of podcasts a few weeks after the live event, but you'll want to make time to catch up with Drs. Gerber and Garon to learn the key highlights with us at the live program and potentially ask some questions of them afterward.

And it's a free program! So register now

Next Previous link

Previous PostNext Post

Related Content

Lung Cancer OncTalk 2023
At our live event, Lung Cancer OncTalk 2023, Dr. Yang, Das, and Dagogo-Jack discuss commonly used terms in treatment options for lung cancer, how oncologists determine the stage of lung cancer, and what that means for treatment, the importance of driver mutation in NSCLC treatment, the vast number of NSCLC trials, among other topics which involve lung cancer treatments. To watch the complete playlist click here.
Lung Cancer OncTalk 2023
At our live event, Lung Cancer OncTalk 2023, Dr. Jeff Yang, discusses different surgical procedures used to treat early-stage lung cancer and different approaches to removing cancerous tissue from the lung. 
Lung Cancer OncTalk 2023
At our live event, Lung Cancer OncTalk 2023, Dr. Millie Das, discusses different Studies and Trials for NSCLC. Dr. Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is the Chief of Oncology at the Palo Alto VA and is an active member of the VA National Lung Cancer Working Group and Lung Cancer Precision Oncology Program. Learn more about Dr. Das here.

Forum Discussions

Hi Amber, Welcome to Grace.  I'm so sorry you're going through this scare.  It could be a recurrence.  It also is as likely to be the contrast creating a better view. ...

Hi Blaze,


As much as I hate to say it, Welcome back Blaze.  It sounds like you're otherwise feeling good and enjoying life which is a wonderful place to be. ...

Waiting for my appointment with oncologist this morning. Thank you for the response. It helps. <3

It sounds like you’re thinking of this in a very appropriate way. Specifically, it sounds like the growth of the nodule is rather modest, though keep in mind that the change...

Hi and welcome to GRACE.  I'm sorry your mom is having this difficulty.  An indwelling catheter is used when the pleura space continually fills and the catheter is always there to...

Recent Comments

Hi Amber, Welcome to Grace. …
By JanineT GRACE … on
Could you
By Maeve785 on
It sounds like you’re…
By Dr West on
Thank you Janine
By blaze100 on